⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL3164509 | 0.72 | — | — | |
| SCHEMBL777500 | 0.71 | — | — | |
| Chloroform SCHEMBL10950487 | 0.71 | LMNA (1.00) | — | |
| Chloroform SCHEMBL10949561 | 0.71 | LMNA (1.00) | — | |
| Chloroform SCHEMBL11043408 | 0.71 | LMNA (1.00) | — | |
| Chloroform SCHEMBL2084455 | 0.71 | — | — | |
| Chloroform SCHEMBL30536988 | 0.71 | — | — | |
| Chloroform SCHEMBL88 | 0.71 | — | — | |
| SCHEMBL406 | 0.71 | — | — | |
| Propene SCHEMBL23404097 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858397-B2 | Dehydration/rehydration of derivatized, marker-loaded liposomes on a test device and method of use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 2010-12-28 | — | — | US | disclosed |
| US-7834029-B2 | Quinolinyl-pyrrolopyrazoles | ELI LILLY AND COMPANY (US) | 2010-11-16 | — | — | US | disclosed |
| US-20090110643-A1 | Method of Producing Liposomes Containing Gas Enclosed Therein | MEBIOPHARM CO., LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20080230383-A1 | DEHYDRATION/REHYDRATION OF DERIVATIZED, MARKER-LOADED LIPOSOMES ON A TEST DEVICE AND METHOD OF USE THEREOF | DURST RICHARD A | 2008-09-25 | — | — | US | disclosed |
| US-7419796-B2 | Method of making a test device | CORNELL RESEARCH FOUNDATION (US) | 2008-09-02 | — | — | US | disclosed |
| US-20080027102-A1 | QUINOLINYL-PYRROLOPYRAZOLES | BEIGHT DOUGLAS W | 2008-01-31 | — | — | US | disclosed |
| US-7265225-B2 | Quinolinyl-pyrrolopyrazoles | ELI LILLY AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| EP-1565471-B1 | QUINOLINYL-PYRROLOPYRAZOLES | LILLY CO ELI (US) | 2006-10-04 | — | — | EP | disclosed |
| US-20060040983-A1 | Quinolinyl-pyrrolopyrazoles | ELI LILLY AND COMPANY (US) | 2006-02-23 | — | — | US | disclosed |
| EP-1192466-B1 | DEHYDRATION/REHYDRATION OF MARKED LIPOSOMES ON A TEST DEVICE | CORNELL RES FOUNDATION INC (US) | 2004-08-11 | — | — | EP | disclosed |
| US-20030104506-A1 | Dehydration/rehydration of derivatized, marker-loaded liposomes on a test device and method of use thereof | DURST RICHARD A (US) | 2003-06-05 | — | — | US | disclosed |
| US-5773435-A | ANTITUMOR AGENTS USING CEPHALOSPORINS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0742015-A1 | Prodrugs for beta-lactamase and uses thereof | Bristol-Myers Squibb Company (US) | 1996-11-13 | — | — | EP | disclosed |
| EP-0484870-A2 | Prodrugs for beta-lactamase and uses thereof | Bristol-Myers Squibb Company (US) | 1992-05-13 | — | — | EP | disclosed |
| US-4412068-A | CULTURING D-STREPTAMINE OR 2,5-SIDEOXYSTREPTAMINE | STERLING DRUG INC. (US) | 1983-10-25 | — | — | US | disclosed |